SRX Global completes $3.472M private stock sale
SRX Global Inc. reported an additional private placement closing under a Securities Purchase Agreement originally dated March 16, 2026.
Rhea-AI Filing Summary
SRX Global Inc. reported an additional private placement closing under a Securities Purchase Agreement originally dated March 16, 2026. The agreement permits the sale of up to 10,000 shares of Series B convertible preferred stock for an aggregate purchase price of up to $8.0 million, together with accompanying warrants.
At the initial March 16, 2026 closing, the company sold 5,660 Series B shares and 22,237,666 warrants for cash proceeds of approximately $4.528 million. On July 27, 2026, at an Additional Closing, it sold 4,340 Series B shares and 284,156 warrants for approximately $3.472 million in cash, with the warrant number reflecting a 60-for-1 reverse stock split effective July 2, 2026.
The securities were issued in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D. These securities are restricted and may not be offered or sold in the United States absent registration or an applicable exemption.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 3.02 — Unregistered Sales of Equity Securities
1 item
Item 3.02
Unregistered Sales of Equity Securities
Securities
The company sold equity securities in a private placement or other unregistered transaction.
Key Figures
Private placement capacity: $8.0 million
Series B shares allowed: 10,000 shares
Initial closing proceeds: $4.528 million
+5 more
8 metrics
Private placement capacity
$8.0 million
Aggregate purchase price available under Securities Purchase Agreement
Series B shares allowed
10,000 shares
Maximum Series B convertible preferred stock under agreement
Initial closing proceeds
$4.528 million
Cash received March 16, 2026 for Series B and warrants
Initial warrants issued
22,237,666 warrants
Warrants to purchase common stock issued at initial closing
Additional closing proceeds
$3.472 million
Cash received July 27, 2026 for Series B and warrants
Additional Series B shares
4,340 shares
Series B preferred issued at Additional Closing
Additional warrants issued
284,156 warrants
Adjusted for 60-for-1 reverse stock split effective July 2, 2026
Reverse stock split ratio
60-for-1
Reverse stock split effective July 2, 2026 impacting warrant count
Key Terms
Securities Purchase Agreement, Series B convertible preferred stock, reverse stock split, Section 4(a)(2), +1 more
5 terms
Securities Purchase Agreement financial
"entered into a Securities Purchase Agreement with certain accredited investors"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Series B convertible preferred stock financial
"up to 10,000 shares of the Company’s Series B convertible preferred stock"
Series B convertible preferred stock is a class of shares sold during a later-stage private financing that combines features of a loan and common stock: it usually pays priority dividends or has a priority claim if the company is sold, and it can be converted into common shares under predefined rules. Investors care because these shares affect ownership stakes and payout order—like having a reserved place in line and a ticket that can turn into regular ownership—so they influence potential returns and dilution for other shareholders.
reverse stock split financial
"adjusted to reflect the Company’s previously announced 60-for-1 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Section 4(a)(2) regulatory
"exemption from registration provided by Section 4(a)(2) of the Securities Act"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
Rule 506 of Regulation D regulatory
"and/or Rule 506 of Regulation D promulgated thereunder"
Rule 506 of Regulation D is a U.S. Securities and Exchange Commission exemption that lets companies sell securities privately without registering them with the SEC, similar to a private party invitation rather than a public auction. It matters to investors because it determines how much information they’ll receive, who can buy (accredited vs. non-accredited), whether public advertising is allowed, and how easily the investment can be resold — all factors that affect risk, transparency and liquidity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SRXH announce regarding its July 27, 2026 private placement?
SRX Global Inc. completed an Additional Closing on July 27, 2026, selling 4,340 Series B preferred shares and 284,156 warrants for approximately $3.472 million in cash. The warrants reflect the company’s 60-for-1 reverse stock split effective July 2, 2026.
What is the total capacity of SRXH’s Securities Purchase Agreement?
The Securities Purchase Agreement allows investors to buy up to 10,000 shares of Series B convertible preferred stock for an aggregate purchase price of up to $8.0 million, together with accompanying warrants. These sales may occur in one or more closings with accredited investors.
What were the terms of SRXH’s initial March 16, 2026 closing?
On March 16, 2026, SRX Global sold 5,660 shares of Series B preferred stock and 22,237,666 warrants in a private placement, receiving approximately $4.528 million in cash proceeds. This transaction occurred under the same Securities Purchase Agreement with certain accredited investors.
How did SRXH’s reverse stock split affect the warrants in the Additional Closing?
The company stated that the 284,156 warrants issued at the Additional Closing were adjusted for its previously announced 60-for-1 reverse stock split, which took effect on July 2, 2026. This adjustment changed the warrant count compared with the larger pre-split warrant issuance in March.
Under what exemptions were SRXH’s securities issued in these private placements?
SRX Global relied on exemptions from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D. The company cited investor representations in the Securities Purchase Agreement and noted that the securities are restricted and cannot be sold without registration or a valid exemption.
Are SRXH’s newly issued securities freely tradable in the United States?
No. SRX Global stated that the securities issued in these private placements were not registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements, consistent with Section 4(a)(2) and Rule 506.
AI-generated analysis. How Rhea-AI works. Not financial advice.
